Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain

M Karachaliou, G Moncunill, A Espinosa… - Scientific reports, 2021 - nature.com
Sparse data exist on the complex natural immunity to SARS-CoV-2 at the population level.
We applied a well-validated multiplex serology test in 5000 participants of a general …

SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia

M Karachaliou, G Moncunill, A Espinosa… - BMC medicine, 2022 - Springer
Background Heterogeneity of the population in relation to infection, COVID-19 vaccination,
and host characteristics is likely reflected in the underlying SARS-CoV-2 antibody …

Temporal trends and differences of SARS-CoV-2-specific antibody responses in symptomatic and asymptomatic subjects: a longitudinal study from Umbria in Italy

I Abraha, P Eusebi, A Germani, E Pasquarelli… - BMJ open, 2022 - bmjopen.bmj.com
Objectives Dynamics of antibody responses following SARS-CoV-2 infection are
controversial in terms of immunity and persistence. We aimed to assess longitudinally the …

Antibodies responses to SARS-CoV-2 in a large cohort of vaccinated subjects and seropositive patients

E Amodio, G Capra, A Casuccio, SD Grazia… - Vaccines, 2021 - mdpi.com
COVID-19 is a current global threat, and the characterization of antibody response is vitally
important to update vaccine development and strategies. In this study we assessed SARS …

Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection

L Canto e Castro, A Gomes, M Serrano… - European Journal of …, 2022 - Wiley Online Library
During the COVID‐19 pandemic, Portugal has experienced three distinct SARS‐CoV‐2
infection waves. We previously documented the prevalence of SARS‐CoV‐2 immunity …

Profiling antibody response patterns in COVID-19: spike S1-reactive IgA signature in the evolution of SARS-CoV-2 infection

G Siracusano, C Brombin, C Pastori… - Frontiers in …, 2021 - frontiersin.org
This contribution explores in a new statistical perspective the antibody responses to severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 141 coronavirus disease 2019 …

SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19

V Glück, S Grobecker, L Tydykov, B Salzberger… - Infection, 2021 - Springer
Objective To follow serological immune responses of front-line healthcare workers after PCR-
confirmed COVID-19 for a mean of 30 weeks, describe the time-course of SARS-CoV-2 …

Evolution of antibodies against SARS-CoV-2 over seven months: Experience of the nationwide seroprevalence ENE-COVID study in Spain

M Perez-Olmeda, JM Saugar… - Journal of Clinical …, 2022 - Elsevier
Background: The main aims of this study were to analyze trends of SARS-CoV-2 anti-
nucleocapsid IgG throughout the four rounds of the seroepidemiologic study ENE-COVID …

Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample

S Stringhini, A Wisniak, G Piumatti, AS Azman… - MedRxiv, 2020 - medrxiv.org
Background Assessing the burden of COVID-19 based on medically-attended case counts is
suboptimal given its reliance on testing strategy, changing case definitions and the wide …

Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study

A Beaumont, C Durand, M Ledrans, V Schwoebel… - BMJ open, 2021 - bmjopen.bmj.com
Objectives We aimed to assess the level of prior SARS-CoV-2 infection in socially deprived
neighbourhoods after the first wave of the pandemic, and to identify factors associated with …